Interestingly, an in silico analysis, which was performed by querying one of the most relevant published datasets on breast cancer patients, comprising 817 tumors, matched normal specimens [73] in order to explore the genetic alterations that might occur at the ODZ4 gene level, revealed that the gene is altered in about 9% of cases. The gene discussed is TENM4; the disease is breast carcinoma.